Prothena Corp (PRTA) PT Raised to $64 at Oppenheimer, Following Clinical Business Update
Tweet
Share
E-mailGet Alerts PRTA Hot Sheet
Price: $8.94 +0.90%
Rating Summary:
15 Buy, 5 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
15 Buy, 5 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
Oppenheimer analyst Jay Olson raised the price target on Prothena Corp (NASDAQ: PRTA) to $64.00 (from $54.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Alchip Technologies Ltd (3661:TT) PT Lowered to NT$5,300 at Nomura/Instinet
- JD Logistics Inc (2618:HK) (JDLGF) PT Raised to HK$18.50 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
